Cell reports (2020) · 피인용 87
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers.

Scientific reports (2019) · 피인용 72
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.

Immunity (2024) · 피인용 71
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.

Molecular cell (2019) · 피인용 91
Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

Cell reports (2019) · 피인용 59
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

Cell (2022) · 피인용 57
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.

Cell metabolism (2020) · 피인용 120
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis.

Developmental cell (2019) · 피인용 79
AMPK Promotes SPOP-Mediated NANOG Degradation to Regulate Prostate Cancer Cell Stemness.

Cell reports (2020) · 피인용 29
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells.

Cancer cell (2024) · 피인용 104
PDGFRα+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay.

Molecular cell (2022) · 피인용 15
Regulation of GTPase function by autophosphorylation.

Cancer discovery (2025) · 피인용 10
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Molecular cell (2019) · 피인용 91
Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

Molecular cell (2022) · 피인용 33
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation.

Cell reports (2022) · 피인용 22
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.

Molecular cell (2022) · 피인용 17
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1.

Cancer research (2025) · 피인용 8
PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability.

Molecular cancer research : MCR (2021) · 피인용 6
RAF-Mutant Melanomas Differentially Depend on ERK2 Over ERK1 to Support Aberrant MAPK Pathway Activation and Cell Proliferation.

Cell reports (2019) · 피인용 87
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.

EBioMedicine (2025) · 피인용 0
Systematic design of DMBT1-derived peptides correlating physicochemical properties and sequence motifs with siRNA delivery and efficacy in cancer therapy.

Cell chemical biology (2023) · 피인용 12
Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions.

Cancer research communications (2026) · 피인용 0
BRAF Inhibition-Associated Nuclear Remodeling is Linked to Cancer-Associated Fibroblast Activation.

Cell reports methods (2021) · 피인용 16
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.